Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not

Journal of Structural Biology

Volumn 140, Issue 1-3, 2002, Pages 180-188

  Wiesmeijer, Karien ^a   Molenaar, Chris ^a   Bekeer, Ivory M L A ^a   Tanke, Hans J ^a   Dirks, Roeland W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CBP; FRAP; PML; Sp100; Time lapse imaging

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; FLUORESCENT DYE; HYBRID PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN DERIVATIVE; PROTEIN SP100; UNCLASSIFIED DRUG;

AUTOFLUORESCENCE; BLEACHING; CELL CULTURE; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CELL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; FIBROBLAST; GENE CONSTRUCT; HUMAN; HUMAN CELL; IMAGING; MOLECULAR DYNAMICS; MOVEMENT (PHYSIOLOGY); OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS;

ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL NUCLEUS; CELLS, CULTURED; HUMANS; LUMINESCENT PROTEINS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PLASMIDS; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0036966365     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-8477(02)00529-4     Document Type: Conference Paper

References (41)

1. Boisvert, F.-M., Hendzel, M.J., Bazett-Jones, D.P., 2000. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148, 283-292.
2. Boisvert, F.-M, Kruhlak, M.J., Box, A.K., Hendzel, M.J., Bazett-Jones, D.P., 2001. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia body. J. Cell Biol. 152, 1099-1106.
3. Chen, D., Craig, S., Hinkley, R., Henry, W., Huang, S., 2002. TBP dynamics in living human cells: constitutive association of TBP with mitotic chromosomes. Mol. Cell. Biol. 13, 276-284.
4. Dirks, R.W., Hattinger, C.M., Molenaar, C., Snaar, S.P., 1999. Synthesis, processing, and transport of RNA within the three-dimensional context of the cell nucleus. Crit. Rev. Eukaryot. Gene Expr. 9, 191-201.
5. Dirks, R.W., Molenaar, C., Tanke, H.J., 2001. Methods for visualizing RNA processing and transport pathways in living cells. Histochem. Cell Biol. 115, 3-11.
6. Dundr, M., Misteli, T., 2001. Functional architecture in the cell nucleus. Biochem. J. 356, 297-310.
7. Everett, R.D., Meredith, M., Orr, A., Cross, A., Kathoria, M., Parkinson, J., 1997. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16, 1519-1530.
8. Everett, R.D., Lomonte, P., Sternsdorf, T., van Driel, R., Orr, A., 1999. Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112, 4581-4588.
9. Gasser, S.M., 2002. Visualizing chromatin dynamics in interphase nuclei. Science 296, 1412-1416.
10. Guo, A., Salomoni, P., Luo, J., Shih, A., Zhong, S., Gu, W., Pandolfi, P.P., 2000. The function of PML in p53-dependent apoptosis. Nature Cell Biol. 2, 730-736.
11. Houtsmuller, A.B., Rademakers, S., Nigg, A.L., Hoogstraten, D., Hoeijmakers, J.H.J., Vermeulen, W., 1999. Action of DNA repair endonuclease ERCC1/XPF in living cells. Science 284, 958-961.
12. Ishov, A.M., Maul, G.G., 1996. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J. Cell Biol. 134, 815-826.
13. Ishov, A.M., Sotnikov, A.G., Negorev, D., Vladimirova, O.V., Neff, N., Kamitani, T., Yeh, E.T.H., Strauss III, J.F., Maul, G.G., 1999. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221-234.
14. Kruhlak, M.J., Levert, M.A., Fischle, W., Verdin, E., Bazett-Jones, D.P., Hendzel, M.J., 2000. The mobility of the GFP-ASF splicing factor in live cells. J. Cell Biol. 150, 41-51.
15. LaMorte, V.J., Dyck, J.A., Ochs, R.L., Evans, R.M., 1998. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA 95, 4991-4996.
16. Lehming, N., Le, S.A., Schüller, J., Ptashne, M., 1998. Chromatin components as part of a putative transcriptional repressing complex. Proc. Natl. Acad. Sci. USA 95, 7322-7326.
17. Leung, A.K.L., Lamond, A.I., 2002. In vivo analysis of NHPX reveals a novel nucleolar localization pathway involving a transient accumulation in splicing speckles. J. Cell Biol. 157, 615-629.
18. Matera, A.G., 1999. Nuclear bodies: multifaceted subdomains of the interchromatin space. Trends Cell Biol. 9, 302-307.
19. Maul, G.G., 1998. Nuclear domain 10, the site of DNA virus transcription and replication. BioEssays 20, 660-667.
20. Misteli, T., Caceres, J.F., Spector, D.L., 1997. The dynamics of a pre-mRNA splicing factor in living cells. Nature 387, 523-527.
21. Müller, S., Matunis, M.J., Dejean, A., 1998. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17, 61-70.
22. Muratani, M., Gerlich, D., Janicki, S.M., Gebhard, M., Eils, R., Spector, D.L., 2002. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus. Nature Cell Biol. 4, 106-110.
23. Negorev, D., Ishov, A.M., Maul, G.G., 2001. Evidence for separate ND10-binding and homo-oligomerization domains of Sp100. J. Cell Sci. 114, 59-68.
24. Negorev, D., Maul, G.G., 2001. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20, 7234-7242.
25. Phair, R.D., Misteli, T., 2000. High mobility of proteins in the mammalian cell nucleus. Nature 404, 604-609.
26. Platani, M., Goldberg, I., Swedlow, J.R., Lamond, A.I., 2000. In vivo analysis of Cajal body movement, separation, and joining in live human cells. J. Cell Biol. 151, 1561-1574.
27. Politz, J.C., Tuft, R.A., Pederson, T., Singer, R.H., 1999. Movement of nuclear poly(A) throughout the interchromatin space in living cells. Curr. Biol. 9, 285-291.
28. Salomoni, P., Pandolfi, P.P., 2002. The role of PML in tumor suppression. Cell 108, 165-170.
29. Seeler, J.-S., Marchio, A., Sitterlin, D., Transy, C., Dejean, A., 1998. Interaction of Sp100 with Hp1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc. Natl. Acad. Sci. USA 95, 7316-7321.
30. Seeler, J.-S, Marchio, A., Losson, R., Desterro, J.M.P., Hay, R.T., Chambon, P., Dejean, A., 2001. Common properties of nuclear body protein Sp100 and TIF1α chromatin factor: role of SUMO modification. Mol. Cell. Biol. 21, 3314-3324.
31. Snaar, S., Wiesmeijer, K., Jochemsen, A.G., Tanke, H.J., Dirks, R.W., 2000. Mutational analysis of fibrillarin and its mobility in living human cells. J. Cell Biol. 151, 653-662.
32. Sternsdorf, T., Jensen, K., Will, H., 1997. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139, 1621-1634.
33. Sternsdorf, T., Jensen, K., Reich, B., Will, H., 1999. The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellutar localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274, 12555-12566.
34. Stuurman, N., de Graaf, A., Floore, A., Josso, A., Humbel, B., de Jong, L., van Driel, R., 1992. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J. Cell Sci. 101, 773-787.
35. Szostecki, C., Guldner, H.H., Netter, H.J., Will, H., 1990. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol. 145, 4338-4347.
36. Tsukamoto, T., Hashiguchi, N., Janicki, S.M., Tumbar, T., Belmont, A.S., Spector, D.L., 2000. Visualization of gene activity in living cells. Nature Cell Biol. 2, 871-878.
37. Tumbar, T., Sudlow, G., Belmont, A.S., 1999. Large-scale chromatin unfolding and remodeling induced by VP16 acidic activation domain. J. Cell Biol. 145, 1341-1354.
38. Wang, Z.-G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R., Pandolfi, P.P., 1998. PML is essential for multiple apoptotic pathways. Nature Genet. 20, 266-272.
39. Wasylyk, C., Schlumberger, S.E., Criqui-Filipe, P., Wasylyk, B., 2002. Sp100 interacts with ETS-1 and stimulates its transcriptional activity. Mol. Cell. Biol. 22, 2687-2702.
40. Wu, W.-S, Vallian, S., Seto, E., Yang, W.-M., Edmondson, D., Roth, S., Chang, K.-S., 2001. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol. Cell. Biol. 21, 2259-2268.
41. Zheng, P., Guo, Y., Niu, Q., Levy, D.E., Dyck, J.A., Lu, S., Sheiman, L.A., Liu, Y., 1998. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature 396, 373-376.